Compounds > aromadedrin
Page last updated: 2024-09-03

aromadedrin and 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one

aromadedrin has been researched along with 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one in 1 studies

Compound Research Comparison

Studies
(aromadedrin)		Trials
(aromadedrin)		Recent Studies (post-2010)
(aromadedrin)		Studies
(5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one)		Trials
(5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one)		Recent Studies (post-2010) (5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one)
890541820145

Protein Interaction Comparison

ProteinTaxonomyaromadedrin (IC50)5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one (IC50)
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)1.48

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chin, YW; Han, SY; Kong, JY1

Other Studies

1 other study(ies) available for aromadedrin and 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one

ArticleYear
Flavonoids as receptor tyrosine kinase FLT3 inhibitors.
    Bioorganic & medicinal chemistry letters, 2013, Mar-15, Volume: 23, Issue:6

    Topics: Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Flavonoids; fms-Like Tyrosine Kinase 3; Humans; Luteolin; Protein Kinase Inhibitors

2013